Insight into the relationship between aryl-hydrocarbon receptor and β-catenin in human colon cancer cells

beta-Catenin is a multi-functional protein involved in cell adhesion and signal transduction and has a critical role in colorectal cancer development. beta-Catenin positively regulates the aryl-hydrocarbon receptor (AhR) mediated signal by both induction of AhR expression and enhancement of AhR-dependent gene induction. Conversely, it was reported that AhR negatively regulates the beta-catenin signal via ubiquitination and subsequent degradation in a ligand dependent manner. However, there have been conflicting data among previous studies regarding the relationship between these two proteins. In this report, we conducted confirmatory studies dissecting the relationship between AhR and beta-catenin. We did not observe beta-catenin degradation by AhR ligands in several colon cancer cell lines. Reporter assays revealed that the AhR ligand did not alter TcF/beta-catenin dependent transcription. Yeast and mammalian two-hybrid assays failed to reconstruct the interaction of beta-catenin and AhR even when other factors, Arnt, CUL4B, and DDB1, were co-expressed additionally. Independently to induction of AhR expression, beta-catenin enhanced AhR-dependent transcriptional activation via the xenobiotic response element (XRE). Coimmunoprecipitation detected the formation of a beta-catenin and ligand-activated AhR complex, which was thought to reflect the beta-catenin mediated enhancement of the AhR signaling. Overall, we could only confirm unidirectional interaction, which is positive regulation of the AhR signal by beta-catenin. These results suggested that data from previous reports on the degradation of beta-catenin via liganded AhR warrants further investigation to yield clarity in the field.